Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Weight Loss Medications: 2025 & Beyond | Dr. Dan | Obesity Expert Fda Approved Anti Obesity Drugs
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-08-22
2025 Weight-Loss Revolution: Game-Changing Medications
If you need assistance in your journey to reach your weight loss goals, book a consultation with me:
✨ Join Dr. Dan’s Empowerment Hub 👉
Discover sustainable, evidence-based solutions to transform your health and embrace self-care without guilt. Connect with a supportive community, get daily affirmations, and create lasting vitality. Don’t wait—click to learn more and start your journey today!
Join this channel to get access to perks:
Download my FREE GLP-1/GIP Medication Information Sheet and 7-Day Food Journal:
Try my fancy dancy Total Daily Energy Expenditure (TDEE) Calculator:
Subscribe to the channel:
–
I’m sharing some exciting advancements in weight-loss medications. We'll cover everything from cutting-edge drugs like Zepbound to new oral options and even some mind-blowing triple-action medications.
Then, we'll get into the exciting stuff – the new medications being approved right now and promising agents in development, including dual agonists, GLP-1 and Glucagon co-agonists, Triple G agonists (that's GLP-1, GIP, and Glucagon!), Amylin co-agonists, cannabinoid receptor agonists, and even some agents that might actually help you build muscle while you lose fat!
Thanks for watching!
00:00 Introduction
00:32 Aren’t current medications enough?
01:45 Dr. Dan’s Empowerment Hub
02:45 Current agents
03:15 New agents for 2025
04:07 Medications in phase 2 and phase 3 trials
04:22 Oral medications
05:35 Agents similar to Zepbound
05:58 GLP-1 and Glucagon Co-Agonists
06:45 Triple G Agonists
07:17 Blue Charm app (promo LYG4G8)
08:02 Amylin Co-Agonists
08:55 Cannabinoid Receptors
09:37 Bimagrumab
10:10 Remaining agents in development
10:45 Final thoughts
References
Nicze M, Dec A, Borówka M, Krzyżak D, Bołdys A, Bułdak Ł, Okopień B. Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy. Int J Mol Sci. 2024 Jul 27;25(15):8202. doi: 10.3390/ijms25158202. PMID: 39125772
Sidrak WR, Kalra S, Kalhan A. Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article. Indian J Endocrinol Metab. 2024 Sep-Oct;28(5):445-460. doi: 10.4103/ijem.ijem_442_23. Epub 2024 Sep 4. PMID: 39676791
Grandl G, Novikoff A, Liu X, Müller TD. Recent achievements and future directions of anti-obesity medications. Lancet Reg Health Eur. 2024 Nov 9;47:101100. doi: 10.1016/j.lanepe.2024.101100. PMID: 39582489
–
Watch my previous videos about how to fight obesity and about the best medicine for weight loss:
▪️ Food Noise:
▪️ Watch This Before Taking Mounjaro:
▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro:
▪️ Managing Nausea from Ozempic, Wegovy and Trulicity!:
▪️ Ozempic: Stomach Paralysis Update:
▪️ How to Switch from Ozempic (or Wegovy) to Mounjaro:
▪️ How to Inject Mounjaro: step-by-step tutorial:
Products I recommend to support your weight-loss journey:
▪️ Managing Constipation:
▪️ Managing Diarrhea:
▪️ Managing Heartburn:
▪️ Internalized Weight Bias:
▪️ Protein Bars:
▪️ Scales and More:
▪️ Supplements:
▪️ Activity Trackers I recommend:
▪️ My favorite Books:
🇺🇸 USA:
🇨🇦 Canada:
–
Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy -
–
Sign up for my newsletter:
–
Contact Me: [email protected]
–
For more about weight loss via habit mastery, visit
Join me on social media:
▪️
▪️
Disclaimer of Medical Liability. HEALTHCARE EVOLUTION INC. DOES NOT PROVIDE MEDICAL ADVICE. The content of this material is for general informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Reliance on any information provided here is solely at your own risk. Individual medical needs are very different; you should not assume that the information in this document concerning certain courses of treatment or outcomes will apply to you. Rather, you should evaluate your medical condition and make treatment decisions based upon consultation with your physician.
#WeightLossMedications #Obesity #WeightLoss
Weight Loss Medications: 2025 & Beyond | Dr. Dan | Obesity Expert For Country: United States. City: Bridgeport, Irving, Long Beach, Louisville, West Valley City
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication